Pyridam Farma (PYFA) Records Significant Growth, Revenue Doubles with a Target of Rp 3 Trillion Next Year pyfadmin November 2, 2024 In its financial report released on October 31, 2024, PT Pyridam Farma Tbk (PYFA) reported a significant increase in sales
PT Pyridam Farma Tbk (PYFA) and RGCC Forge Strategic Partnership, Bringing Cancer Treatment Innovation to Indonesia pyfadmin October 22, 2024 In a joint effort to combat cancer and improve access to quality treatments, PT Pyridam Farma Tbk (PYFA) and Research
PYFAGROUP’s Commitment to the Nation’s Health is Realized Through the Expansion of Ethica Industri Farmasi’s Injection Production Facility pyfadmin September 17, 2024 Jakarta, September 12, 2024 – PT Ethica Industri Farmasi, a pharmaceutical company under the PYFAGROUP, has officially commenced the groundbreaking
PYFAGROUP Becomes the First to Launch CDMO Services in the Global Pharmaceutical Industry pyfadmin August 9, 2024 Jakarta, August 9, 2024 – Anticipating the rapid growth of the health product market, PYFAGROUP, comprising leading pharmaceutical companies Pyridam
Pyridam Farma Acquires Major Australian Pharmaceutical Company, Expands into Global Market. pyfadmin June 20, 2024 Jakarta, August 9, 2024 – Anticipating the rapid growth of the health product market, PYFAGROUP, comprising leading pharmaceutical companies Pyridam
PYFAESTHETIC Successfully Holds Soft Launching of Carboxy Therapy in Jakarta and Surabaya pyfadmin June 11, 2024 Jakarta, 11 June 2024 – PYFAESTHETIC, a business unit of PT Pyridam Farma Tbk, has successfully held a soft launch
PYFAESTHETIC Holds Another Cadaver Training in Manila pyfadmin June 5, 2024 Jakarta, June 5, 2024 – PYFAESTHETIC, a subsidiary of PT Pyridam Farma Tbk (PYFA) engaged in dermatology and aesthetics, has
Pyridam Farma and Medomics Launch Innovative Rapid Test for Vulvovaginitis Diagnosis pyfadmin June 3, 2024 Jakarta, June 3, 2024 – Vulvovaginitis is a common gynecological condition affecting women of reproductive age. Symptoms often include vaginal
Pyridam Farma Distributes Osteoporosis Medication from EffRx Pharmaceuticals Swiss pyfadmin May 2, 2024 Jakarta, May 2, 2024 – EffRx Pharmaceuticals SA, a Swiss pharmaceutical company focused on developing and commercializing musculoskeletal and rare
Pyfaesthetic Participates in IMCAS World Congress 2024 in Paris pyfadmin March 5, 2024 Jakarta, March 5, 2024 – Pyfaesthetic, a business unit of PT Pyridam Farma Tbk, successfully participated in the IMCAS World